HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angioedema

Swelling involving the deep DERMIS, subcutaneous, or submucosal tissues, representing localized EDEMA. Angioedema often occurs in the face, lips, tongue, and larynx.
Also Known As:
Angioneurotic Edema; Angioedemas; Angioneurotic Edemas; Edema, Angioneurotic; Edema, Quincke's; Edemas, Angioneurotic; Giant Urticaria; Giant Urticarias; Quincke Edema; Quinckes Edema; Urticarias, Giant; Quincke's Edema; Urticaria, Giant
Networked: 3162 relevant articles (139 outcomes, 222 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Urticaria (Hives)
2. Hereditary Angioedemas
3. Chronic Urticaria
4. Pruritus (Itching)
5. Anaphylaxis (Anaphylactic Shock)

Experts

1. Cicardi, Marco: 42 articles (07/2021 - 08/2002)
2. Bernstein, Jonathan A: 36 articles (01/2022 - 01/2008)
3. Farkas, Henriette: 32 articles (01/2022 - 09/2004)
4. Maurer, Marcus: 31 articles (10/2021 - 06/2008)
5. Bouillet, Laurence: 26 articles (01/2021 - 09/2004)
6. Bygum, Anette: 23 articles (06/2021 - 11/2008)
7. Kaplan, Allen P: 22 articles (02/2022 - 01/2002)
8. Zanichelli, Andrea: 22 articles (01/2020 - 09/2002)
9. Banerji, Aleena: 20 articles (07/2022 - 11/2006)
10. Bouillet, L: 20 articles (12/2020 - 01/2003)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Angioedema:
1. Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
2. BradykininIBA
3. Histamine Antagonists (Antihistamines)IBA
4. Omalizumab (Xolair)FDA Link
5. icatibantIBA
6. Adrenal Cortex Hormones (Corticosteroids)IBA
7. Danazol (Azol)FDA LinkGeneric
8. Epinephrine (Adrenaline)FDA LinkGeneric
9. Antihypertensive Agents (Antihypertensives)IBA
10. Bradykinin B2 ReceptorIBA

Therapies and Procedures

1. Therapeutics
2. Injections
3. Immunotherapy
01/01/2019 - "Oral immunotherapy increased serious adverse events (RR 1·92 [1·00-3·66], I2=0%, RD 5·7%, moderate-certainty), and non-anaphylactic reactions (vomiting: RR 1·79 [95%CI 1·35-2·38], I2=0%, high-certainty; angioedema: 2·25 [1·13-4·47], I2=0%, high-certainty; upper tract respiratory reactions: 1·36 [1·02-1·81], I2=0%, moderate-certainty; lower tract respiratory reactions: 1·55 [0·96-2·50], I2=28%, moderate-certainty). "
01/01/2014 - "Initial specific immunotherapy had to be stopped due to severe anaphylaxis (hypotension, dyspnea, and angioedema). "
03/01/2018 - "We include information from articles on asthma, allergic rhinitis, rhinosinusitis, immunotherapy, atopic dermatitis, contact dermatitis, food allergy, anaphylaxis, drug hypersensitivity, urticarial/angioedema, eosinophilic disorders, and immunodeficiency. "
01/01/2020 - "This article provides highlights of the clinically impactful original studies and reviews published in The Journal of Allergy and Clinical Immunology: In Practice in 2019 on the subjects of anaphylaxis, asthma, dermatitis, drug allergy, food allergy, immunodeficiency, immunotherapy, rhinitis/sinusitis, and urticaria/angioedema/mast cell disorders. "
01/01/2016 - "Whereas sufficient high-quality trials exist for the specific immunotherapy of allergic rhinitis and in a limited measure also for the angiotensin-converting enzyme inhibitor induced angioedema, the evidence for Menière's disease or for pharmacotherapy of postoperative laryngeal edema is rather poor. "
4. Dental Care
5. Drug Therapy (Chemotherapy)